tafamidis and Liver-Diseases

tafamidis has been researched along with Liver-Diseases* in 1 studies

Other Studies

1 other study(ies) available for tafamidis and Liver-Diseases

ArticleYear
Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
    Internal medicine (Tokyo, Japan), 2017, Dec-01, Volume: 56, Issue:23

    A 54-year-old man with polycystic liver disease received a domino liver transplantation (DLT) from a patient of hereditary ATTR amyloidosis with the transthyretin Ser50Arg mutation. Ten years after transplantation, he felt a slight numbness in his toes, and cardiac amyloidosis was simultaneously suspected upon a heart function evaluation. Biopsy specimens from the myocardium revealed transthyretin amyloidosis with the Ser50Arg mutation. Oral tafamidis therapy has inhibited the progression of neurological and cardiovascular symptoms this far. We herein report this first case of amyloid polyneuropathy and myocardial amyloidosis after DLT from hereditary ATTR amyloidosis with a transthyretin Ser50Arg mutation and discuss similar cases of other mutations.

    Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cysts; Humans; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mutation; Prealbumin; Treatment Outcome

2017